Navigation Links
Azathioprine Can Soon Revolutionize Eczema Treatment

Azathioprine, an immunosuppressant, meant for use in kidney transplant recipients can be used in treatment of eczema, a skin disorder. The drug was discovered 40 years ago, is still used to prevent the rejection of transplanted kidneys// in renal failure patients.

In around the 1960s, Roy Calne showed that azathioprine prevented the rejection of canine kidney transplants. Following this finding, a combination of azathioprine and corticosteroids were developed, for use in patents with transplanted kidneys.

Atopic eczema is a skin disorder that affects nearly 10-15% of children. Approximately one-third of these children carry the disease symptoms, into adulthood. High doses of topical steroid creams are given. This is however not a very effective form of treatment. The lack of a proper available treatment sparked interest among the researchers, in search of a more effective treatment.

Although, some Dermatologists believed that azathioprine could be useful in eczema treatment, no clinical trials had been initiated so far. Nearly 63 patients with atopic eczema, a most common form of the disease were taken up into a 3- month clinical trial.

All the study participants had undergone a variety of treatments, including radiation therapy with ultraviolet light. Surprisingly, treatment with azathioprine was found to cure the irritating skin condition. Although the drug can have serious side effects such as increased susceptibility to infections, it can be minimized by modulating the drug dosage depending on the ability of the patient to metabolize the drug.

'I'd tried everything so had no hesitation in taking part in the trial. At its worst, I'd been covered from head to toe in eczema sores. It was so painful it stopped me from sleeping at night and it affected what I would wear because I tried to cover it up as much as possible. My eczema disappeared within a couple of months. It was the first time I'd been clear of eczema since I was a child,' remarked Lindsay Dodds, one of the study participants.

This path-breaking research has been conducted by Dr Simon Meggitt, Dermatologist, Newcastle's Royal Victoria Infirmary, in association with Prof Nick Reynolds at Newcastle University. 'This kind of promising development illustrates why we are so dedicated to raising funds for research into eczema and related skin disorders that blight so many people's lives,' said Matthew Patey, British Skin Foundation.


Related medicine news :

1. Skin cancer linked to usage of Drug Azathioprine in organ transplants
2. Azathioprine to Treat Eczema?
3. Azathioprine 50mg Pills Recalled By FDA And Roxane Labs
4. Complete Robotic Surgery To Revolutionize Surgical Treatment of Prostate Cancer
5. LINK Applied Genomics Programme Promises To Revolutionize Healthcare Systems
6. Heart Stem Cells Could Revolutionize Cardiac Disease Therapy
7. Monoclonal Anti-Body To Revolutionize Brain Cancer Treatment
8. Bio-Functional Garments That Could Revolutionize Fashion Industry
9. New Technique Could Revolutionize Melanoma Diagnosis and Treatment
10. Absorption Of Carbon Nanotube Measured In Worms Revolutionize Cancer Research
11. Terahertz Imaging Promises To Revolutionize Breast Cancer Treatments
Post Your Comments:

(Date:10/12/2017)... ... October 12, 2017 , ... ... treating sleep apnea using cutting-edge Oventus O2Vent technology. As many as ... disorder characterized by frequent cessation in breathing. Oral appliances can offer significant relief ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... the demand of today’s consumer and regulatory authorities worldwide. From Children’s to Adults ... tested to meet the highest standard. , These products are also: Gluten ...
(Date:10/12/2017)... ... October 12, 2017 , ... The American College of ... Carol Friedman, PhD, FACMI, during the Opening Session of AMIA’s Annual Symposium in Washington, ... In honor of Morris F. Collen, a pioneer in the field of medical informatics, ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information about the technology: , ... to enable prevention of a major side effect of chemotherapy in children. Cisplatin ... patients. For cisplatin, hearing loss is FDA listed on-label as a dose limiting ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... HMP ... the recipient of a 2017 Folio Magazine Eddie Digital Award for ‘Best B-to-B Healthcare ... City on October 11, 2017. , The annual award competition recognizes editorial and design ...
Breaking Medicine News(10 mins):
(Date:9/27/2017)... and NEW YORK , Sept. 27, 2017  DarioHealth ... and big data solutions, today announced that its MyDario product is expected ... local TV listings for when The Dr. Oz Show airs in your ... The nine-time Emmy ... ...
(Date:9/22/2017)... Md. , Sept. 22, 2017  As the ... Republican Senators Bill Cassidy (R-LA) and ... Information notes that the medical device industry is in ... medical device tax, the 2.3% excise tax on medical ... But they also want covered patients, increased visits and ...
(Date:9/18/2017)... KALAMAZOO, Mich. , Sept. 18, 2017 /PRNewswire/ ... and OptiMed Specialty Pharmacy of Kalamazoo, Mich. ... a strategic hub service that expedites and streamlines patient ... spirometer, Spiro PD 2.0, and wellness management services.  ... a medical device used to measure lung function for ...
Breaking Medicine Technology: